Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties

JAMA

Volumn 279, Issue 7, 1998, Pages 526-531

  Pincus, Harold Alan ^a   Tanielian, Terri L ^a   Marcus, Steven C ^b   Olfson, Mark ^c   Zarin, Deborah A ^a   Thompson, James ^a,d   Magno Zito, Julie ^e  

^a AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; GENERAL PRACTITIONER; HUMAN; MEDICAL SPECIALIST; MENTAL DISEASE; NORMAL HUMAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; UNITED STATES;

EID: 0032542541     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.7.526     Document Type: Article

References (37)

1. Glaser M. Annual Rx survey hats off. Drug Topics. 1995;139:43-48.
2. Olfson M, Klerman GL. The treatment of depression: prescribing practices of primary care physicians and psychiatrists. J Fam Pract. 1992;35:627-635.
3. Beardsley RS, Gardocki GJ, Larson DB, Hidaldo J. Prescribing of psychotropic medication by primary care physician and psychiatrists. Arch Gen Psychiatry. 1988;45:1117-1119.
4. Olfson M, Klerman GL. Trends in the prescription of psychotropic medications: the role of physician specialty. Med Care. 1993;31:559-564.
5. Zarin DA, Pincus HA, McIntyre JS. Practice guidelines. Am J Psychiatry. 1993;150:175-177.
6. Depression Guideline Panel. Depression in Primary Care. Rockville, Md: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
7. American Psychiatric Association. Practice Guidelines. Washington, DC: American Psychiatric Press Inc; 1996
8. Weintraub M, Singh S, Byrne L, Maharaj K, Guttmacher L. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations. JAMA. 1991;266:2392-2397.
9. Glass RM. Benzodiazepine prescription regulation: autonomy and outcome. JAMA. 1991;266:2431-2433.
10. Pincus HA, Zarin DA, West JC. Peering into the black box: measuring outcomes of managed care. Arch Gen Psychiatry. 1996;53:870-877.
11. McLemore T, Delozier J. National Ambulatory Medical Care Survey, 1985 Summary. Hyattsville, Md: National Center for Health Statistics; 1987.
12. Woodwell DW, Schappert SM. National Ambulatory Medical Care Survey, 1993 Summary: Advance Data From Vital and Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1995.
13. Schappert SM. National Ambulatory Medical Care Survey, 1994 Summary: Advance Data From Vital and Health Statistics. Hyattsville, Md: National Center for Health Statistics; 1995.
14. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co Inc; 1994.
15. American Medical Association. Drug Evaluations Annual 1994. Chicago, Ill: American Medical Association; 1994.
16. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
17. Kroenke K. Discovering depression in medical patients: reasonable expectations. Ann Intern Med. 1997;126:463-465.
18. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co Inc; 1997.
19. Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 1992;15:1-27.
20. Wallis C. An epidemic of attention deficit disorder. Time. 1994;144:42-50.
21. Safer DJ, Krager JM. A survey of medication treatment for hyperactive/inattentive students. JAMA. 1988;260:2256-2258.
22. Swanson JM, McBurnett K, Christian D, Wigal T. Stimulant medications and the treatment of children with ADHD. Adv Clin Child Psychol. 1995;17: 265-322.
23. Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med. 1995;333:944.
24. Wolkowitz OM, Pickar D. Benzodiazepines in the treatment of schizophrenia: a review and a reappraisal. Am J Psychiatry. 1991;148:714-726.
25. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus halperidol: a double-blind study. Arch Gen Psychiatry. 1992;53: 47-52.
26. Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania: a controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry. 1975;32:34-42.
27. Amsterdam JD, Hornig-Rohan M, Maislin G. Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression. J Clin Psychiatry. 1994;55:394-400.
28. Arana GW, Hyman SE. Handbook of Psychiatric Drug Therapy. 2nd ed. Boston, Mass: Little Brown & Co Inc; 1991.
29. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry. 1994;151(suppl):1-36.
30. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 1997;154(suppl):1-63.
31. Pincus HA. Assessing the effects of physician payment on treatment of mental disorders in primary care. Gen Hosp Psychiatry. 1990;12:23-29.
32. Rogers WH, Wells KB, Meredith LS, Strum R, Burnham MA. Outcomes for adult patients under pre-paid or fee-for-service financing. Arch Gen Psychiatry. 1993;50:517-525.
33. Regier DA, Hirschfeld RM, Goodwin FK, Burke JD, Lazar JB, Judd LL. The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry. 1988;145:1351-1357.
34. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. JAMA. 1997;277:333-340.
35. Kessler RC, McGonagle KA, Zhao S, et al. Life-time and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
36. Kramer PD. Listening to Prozac. New York, NY: Viking Penguin; 1993.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.